Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Most people shopping for a GLP-1 online make the same error: they search for the lowest price and assume the cheapest option is the biggest risk. The real risk is opacity. Unnamed pharmacies, no lot tracking, no pharmacy credential you can verify. Price matters. So does knowing exactly where your medication comes from.
Here are eight options worth considering, ranked by overall value for a typical cash-pay patient.
The monthly price for compounded semaglutide opens at $99. Tirzepatide starts at $149. Those are genuinely low numbers for this category, and the pharmacy behind them is named: Manifest Pharmacy in Greer, South Carolina, a 503A-compliant facility operating under USP-797 standards with lot-to-door tracking. LegitScript-certified (certificate 50087439). You can look that up.
The process is straightforward. Complete an online health assessment, a US board-certified physician reviews it within roughly 24 hours, and medication ships overnight to all 50 states at no added cost. No contracts, upfront pricing.
The clinical trials HealthRX references for its medications are real ones: SURMOUNT-1 showed tirzepatide averaging about 21% body weight reduction at 72 weeks; STEP 1 showed semaglutide averaging around 15% at 68 weeks. HealthRX does not claim its compounded versions are equivalent to brand-name drugs. Important distinction.
Best for: Cash-pay patients who want low entry pricing, a verifiable pharmacy, and nationwide overnight delivery.
Where HealthRX wins on price and reach, FormBlends wins on documentation. Every product comes with published purity testing: HPLC purity figures, mass spec identity confirmation, endotoxin and sterility results, with actual numbers attached. Most GLP-1 telehealth brands say their pharmacy is “quality-tested.” FormBlends shows you the data.
Compounded semaglutide runs around $299, tirzepatide around $349. Noticeably higher than HealthRX. Ships to 47 states. Physician oversight is part of the model, dispensed through an FDA-registered 503A compounding pharmacy.
One thing that sets it apart beyond GLP-1s: FormBlends carries a wider peptide catalog covering recovery, longevity, and cognitive compounds under the same clinician model. If you want GLP-1 therapy plus, say, BPC-157 or other research peptides from one provider with consistent oversight, this is worth a serious look.
Best for: Patients who prioritize published purity data, or who want GLP-1 treatment bundled with a broader peptide program.
Mochi puts obesity-medicine board-certified clinicians in the loop, not just general practitioners doing quick intake approvals. That level of clinical oversight shows in the monitoring cadence. Compounded semaglutide runs about $99 a month, tirzepatide about $199. The higher tirz price compared to HealthRX is offset, for some patients, by the more hands-on clinical relationship.
Best for: Patients who want more medical oversight than a basic telehealth intake provides.
After the March 2026 Novo Nordisk settlement, Hims & Hers moved away from compounded GLP-1s toward branded medications. Injectable Wegovy is listed around $299 a month, oral options around $249, and Zepbound around $399. With insurance plus a savings card, some patients get to near-zero monthly cost. Big infrastructure, widely recognized brand.
Best for: Patients with insurance coverage or access to manufacturer savings programs.
Ro charges about $39 for the first month, then $74 to $149 monthly, with medications billed separately. They have a prior-authorization team that actually works to get insurance coverage for branded drugs. That alone saves some patients hundreds of dollars.
Best for: Anyone who needs insurance prior-auth support and wants a name brand behind the process.
Cash-pay compounded GLP-1s, first month typically $179 to $249, with a lighter monitoring structure than Mochi. Shipping runs 24 to 72 hours. Good option if you want fast access and lower cost without a heavy coaching layer.
Best for: Patients who know what they want and prefer a lean, fast intake process.
PlushCare’s membership fee is about $19.99 a month, among the lowest platform costs in this space. It handles branded medications and accepts insurance, with same-day appointments available. It is not compounded-medication-focused, but for someone already on a branded GLP-1 and looking for a low-cost telehealth home, it works.
Best for: Branded-medication patients who want insurance billing and low monthly overhead.
Found charges around $99 a month for the platform, with medications priced separately. It includes coaching alongside the prescription component. The combined cost adds up faster than cash-pay compounded options, but the coaching structure suits people who want behavioral support built in rather than bolted on later.
Best for: Patients who want lifestyle coaching and medication management in one subscription.
A note on the category overall: FDA warning letters went out to more than 30 telehealth and compounding firms in early 2026. The space is being watched. Always verify a pharmacy’s credentials independently before ordering anything injectable.
No. Compounded semaglutide contains the same active molecule, but it is not FDA-approved and has not gone through the same manufacturing review as branded products. Clinics like HealthRX and FormBlends acknowledge this openly. The lower price reflects that difference, not necessarily lower quality, but the distinction is real and legally significant.
Check the pharmacy’s name against the LegitScript database at legitscript.com and confirm 503A status through the FDA’s compounding pharmacy list at fda.gov. HealthRX names its pharmacy, Manifest Pharmacy, and publishes a LegitScript certificate number. That kind of transparency is the baseline you should expect from any provider.
FormBlends publishes batch-specific lab data, including HPLC purity figures and endotoxin results, which adds testing cost. It also offers a broader peptide catalog under physician oversight. You are paying for documentation and range of products, not just the semaglutide itself. Whether that premium is worth it depends on how much the data matters to you.
HealthRX, FormBlends, Mochi Health, and Henry Meds were still operating compounded GLP-1 programs as of 2026. Hims & Hers shifted toward branded medications following its March 2026 Novo Nordisk settlement. The regulatory situation is still moving, so confirming current availability directly with any provider before starting is worth the extra step.
No. Both platforms bill medications separately from the membership or platform fee. Ro’s $39 first-month price covers platform access, not the drug itself. Found’s $99 monthly fee covers coaching and prescription management. Budget for both line items when comparing total monthly cost against cash-pay compounded options from clinics like HealthRX or Henry Meds.